ZIMTHRU Trademark
Trademark Overview
On Monday, January 29, 2024, a trademark application was filed for ZIMTHRU with the United States Patent and Trademark Office. The USPTO has given the ZIMTHRU trademark a serial number of 98381207. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 13, 2025. This trademark is owned by Renibus Therapeutics, Inc.. The ZIMTHRU trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing heart disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement
General Information
| Serial Number | 98381207 |
| Word Mark | ZIMTHRU |
| Filing Date | Monday, January 29, 2024 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, May 13, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 26, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing heart disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 29, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Renibus Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Southlake, TX 76092 |
| Party Name | Renibus Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Southlake, TX 76092 |
Trademark Events
| Event Date | Event Description |
| Monday, January 29, 2024 | NEW APPLICATION ENTERED |
| Tuesday, May 28, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 23, 2024 | ASSIGNED TO EXAMINER |
| Monday, September 2, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, October 31, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 31, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 31, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, September 2, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 2, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, November 1, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 26, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 26, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 24, 2024 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Sunday, April 6, 2025 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, May 13, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
